Dr. Finn Speaks at VIVA 2019 & VEINS

Dr. Aloke Finn traveled to Las Vegas for the VIVA 2019 & VEINS conference, November 5-7 where he was a member of the presenting faculty.  Dr. Finn spoke on the topics of “How the FDA defines Atherectomy: Evolving Definition and Nomenclature” in the government regulatory session and “When to use DCB and When to use DES for Short (>5 cm) Tibial Occlusive Disease in Patients” during the Roundtable on Below-the-Knee Drug Delivery.  He also participated as a panelist in the session on Late-Breaking Clinical Trials.